Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Limited predictive value of PD-L1 TPS for pathological response in NSCLC is not attributable to interobserver variability.

Lung cancer (Amsterdam, Netherlands)·2026
Same author

Redefining therapeutic horizons in thymic epithelial tumors: precision, combinations, and emerging biology.

NPJ precision oncology·2026
Same author

In Reply.

Archives of pathology & laboratory medicine·2026
Same author

Progress in Thymic Malignancy Care: The Imperative for Global Standards and Collaboration.

European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery·2026
Same author

Pulmonary venoocclusive disease/pulmonary capillary hemangiomatosis: Inadequacy of clinico-radiologic features in diagnosis.

Human pathology·2026
Same author

International Society for Heart and Lung Transplantation Scientific Statement on pulmonary antibody-mediated rejection and proposed graft, antibody, and pathology (GAP) definition.

The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation·2026
Same journal

Pathobiology and Interactions of the MiTF Signaling Pathways.

Advances in anatomic pathology·2026
Same journal

Diagnosis and Reporting of Intraductal Carcinoma of the Prostate: A Guide for Practising Pathologists With Excerpts From the Genitourinary Pathology Society and the International Society of Urological Pathology Joint Expert Consultation.

Advances in anatomic pathology·2026
Same journal

An Update on Soft Tissue Tumors of the Paratesticular Region.

Advances in anatomic pathology·2026
Same journal

Recognizing Familial Thyroid Neoplasia: The Pathologist's Role in Diagnosis and Management.

Advances in anatomic pathology·2026
Same journal

Hereditary and Familial Tumor Syndromes: When to Think of Them? The Emerging Role of Pathologists as Sentinels of Genetic Cancer Predisposition.

Advances in anatomic pathology·2026
Same journal

From Familial Clustering to a Dedicated Classification: The Historical Recognition of Hereditary Tumor Syndromes in the WHO Classification of Tumors.

Advances in anatomic pathology·2026
查看所有相关文章

相关实验视频

Updated: Jun 30, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K

分子定义的胸部新生体.

Anja C Roden1

  • 1Department of Laboratory Medicine and Pathology, Mayo Clinic Rochester, Rochester, MN.

Advances in anatomic pathology
|March 19, 2024
PubMed
概括
此摘要是机器生成的。

越来越多地认识到分子定义的胸部瘤,如NUT癌瘤和SMARCA4缺乏的未分化瘤. 诊断对于有针对性的疗法和临床试验至关重要,改善了患者管理.

更多相关视频

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K
Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery
07:30

Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery

Published on: May 4, 2022

3.4K

相关实验视频

Last Updated: Jun 30, 2025

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.1K
Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors
11:15

Next Generation Sequencing for the Detection of Actionable Mutations in Solid and Liquid Tumors

Published on: September 20, 2016

24.4K
Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery
07:30

Electromagnetic Navigation Transthoracic Nodule Localization for Minimally Invasive Thoracic Surgery

Published on: May 4, 2022

3.4K

科学领域:

  • 胸部瘤学 胸部瘤学
  • 分子病理学分子病理学
  • 新生体的分类新生体的分类.

背景情况:

  • 分子研究正在加强对瘤发病的表征和理解.
  • 越来越多地被认可的胸部瘤包括NUT瘤,SMARCA4缺乏的未分化瘤 (DUT),EWSR1::CREB1融合的肺髓状瘤,透明细胞瘤和SMARCB1缺乏的瘤.
  • 特定免疫质 (NUT,BRG1,INI-1) 和细胞遗传学研究 (EWSR1) 的可用性有助于诊断这些罕见的瘤.

研究的目的:

  • 审查有关特定罕见胸部瘤的临床,形态,免疫类型和分子特征的当前知识.
  • 突出准确诊断对患者管理和治疗策略的重要性.

主要方法:

  • 对临床,形态,免疫类型和分子数据的审查.
  • 重点是诊断工具,包括免疫蛋白和细胞遗传学.
  • 对已确认的新生体进行文献综述.

主要成果:

  • 分子定义的胸部瘤变得越来越容易识别.
  • 诊断标记物如NUT,BRG1和INI-1免疫蛋白,以及EWSR1细胞遗传学,是识别的关键.
  • 准确的诊断有助于对某些瘤进行专门的临床试验.

结论:

  • 改进对分子定义的胸部瘤的识别是必不可少的.
  • 诊断方面的进步使得更好的患者分层和治疗选择成为可能.
  • 了解这些罕见的瘤对于推进胸部瘤治疗至关重要.